Long Grove Pharms Company Profile
✉ Email this page to a colleague
What is the competitive landscape for LONG GROVE PHARMS, and when can generic versions of LONG GROVE PHARMS drugs launch?
LONG GROVE PHARMS has ten approved drugs.
There are six US patents protecting LONG GROVE PHARMS drugs.
There are two patent family members on LONG GROVE PHARMS drugs in two countries and eighty supplementary protection certificates in thirteen countries.
Summary for Long Grove Pharms
| International Patents: | 2 |
| US Patents: | 6 |
| Tradenames: | 11 |
| Ingredients: | 10 |
| NDAs: | 10 |
Drugs and US Patents for Long Grove Pharms
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Long Grove Pharms | ERIBULIN MESYLATE | eribulin mesylate | SOLUTION;INTRAVENOUS | 214850-001 | Jul 18, 2024 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Long Grove Pharms | EDARAVONE | edaravone | SOLUTION;INTRAVENOUS | 218354-001 | May 6, 2024 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Long Grove Pharms | TRIAMCINOLONE ACETONIDE | triamcinolone acetonide | INJECTABLE;INJECTION | 213543-001 | Jan 19, 2022 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Long Grove Pharms Drugs
Supplementary Protection Certificates for Long Grove Pharms Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 0186405 | SPC/GB00/021 | United Kingdom | ⤷ Sign Up | PRODUCT NAME: (1-HYDROXY-2-(3-PYRIDINYL)ETHYLIDENE)BIS(PHOSPHONIC ACID) "RESIDRONATE" AND SALTS THEREOF, ESPECIALLY THE SODIUM SALT; REGISTERED: SE 15296 19991007; SE 15297 19991007; UK PL 00364/0070 20000316 |
| 3141251 | SPC/GB20/075 | United Kingdom | ⤷ Sign Up | PRODUCT NAME: A MEDICINAL PRODUCT CONSISTING OF A COMBINATION OF A FIRST DOSE PHARMACEUTICAL COMPOSITION AND A SECOND DOSE PHARMACEUTICAL COMPOSITION, THE FIRST DOSE PHARMACEUTICAL COMPOSITION CONSISTING OF THE ACTIVE INGREDIENTS: POLYETHYLENE GLYCOL 3350, SODIUM SULPH; REGISTERED: IS IS/1/17/063/01 20171016; UK PL 20011/0040 20171016 |
| 1758590 | LUC00029 | Luxembourg | ⤷ Sign Up | PRODUCT NAME: SEL DE SODIUM D'ACIDE DEOXYCHOLIQUE; AUTHORISATION NUMBER AND DATE: IS/1/16/071/01 20170401 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
